VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 101 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 17.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $58 | -54.7% | 7,572 | -54.4% | 0.00% | – |
Q1 2023 | $128 | -93.6% | 16,623 | +2196.0% | 0.00% | – |
Q3 2021 | $2,000 | -83.3% | 724 | -72.6% | 0.00% | – |
Q1 2021 | $12,000 | -20.0% | 2,642 | +80.3% | 0.00% | – |
Q3 2020 | $15,000 | +7.1% | 1,465 | +32.0% | 0.00% | – |
Q2 2020 | $14,000 | -26.3% | 1,110 | -47.0% | 0.00% | – |
Q1 2020 | $19,000 | -87.1% | 2,095 | -80.2% | 0.00% | – |
Q4 2019 | $147,000 | +32.4% | 10,598 | +63.1% | 0.00% | – |
Q3 2019 | $111,000 | -82.9% | 6,499 | -72.8% | 0.00% | -100.0% |
Q2 2019 | $650,000 | +112.4% | 23,897 | +49.2% | 0.00% | +100.0% |
Q1 2019 | $306,000 | – | 16,016 | +16242.9% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 98 | -74.7% | 0.00% | – |
Q3 2018 | $7,000 | +40.0% | 387 | +41.8% | 0.00% | – |
Q2 2018 | $5,000 | -28.6% | 273 | -26.8% | 0.00% | – |
Q1 2018 | $7,000 | -96.6% | 373 | -97.0% | 0.00% | -100.0% |
Q4 2017 | $207,000 | +2487.5% | 12,516 | +2982.8% | 0.01% | – |
Q3 2017 | $8,000 | – | 406 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 3,851,507 | $29,849,179 | 1.01% |
ARMISTICE CAPITAL, LLC | 4,178,000 | $32,379,500 | 0.50% |
SummerHaven Investment Management, LLC | 72,779 | $564,037 | 0.41% |
GLOBEFLEX CAPITAL L P | 453,595 | $3,515,361 | 0.41% |
Ikarian Capital, LLC | 305,857 | $2,370,392 | 0.28% |
Hillsdale Investment Management Inc. | 367,590 | $2,848,824 | 0.26% |
SILVERARC CAPITAL MANAGEMENT, LLC | 103,966 | $805,737 | 0.24% |
Parkman Healthcare Partners LLC | 60,322 | $467,496 | 0.09% |
Inspire Investing, LLC | 82,656 | $640,584 | 0.08% |
HUSSMAN STRATEGIC ADVISORS, INC. | 52,500 | $406,875 | 0.08% |